Literature DB >> 23319101

Causes and treatment of oedema in patients with heart failure.

Andrew L Clark1, John G F Cleland.   

Abstract

Oedema is one of the fundamental features of heart failure, but the pathophysiology of oedema varies. Patients present along a spectrum ranging from acute pulmonary oedema to gross fluid retention and peripheral oedema (anasarca). In patients with pure pulmonary oedema, the problem is one of acute haemodynamic derangement; the patient does not have excess fluid, but pulmonary venous pressure rises such that the rate of fluid transudation into the interstitium of the lung exceeds the capacity of the pulmonary lymphatics to drain away the fluid. Conversely, in patients with peripheral oedema, the problem is one of fluid retention. Understanding the causes of oedema will enable straightforward, correct management of the condition. For patients with acute pulmonary oedema, vasodilatation is important to reduce cardiac filling pressures. For patients with fluid retention, removing the fluid, using either diuretics or mechanical means, is the most important consideration.

Entities:  

Mesh:

Year:  2013        PMID: 23319101     DOI: 10.1038/nrcardio.2012.191

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  176 in total

1.  Blood pressure-independent effect of long-term treatment with the soluble heme-independent guanylyl cyclase activator HMR1766 on progression in a model of noninflammatory chronic renal damage.

Authors:  Kerstin Benz; Stephan R Orth; Aurelia Simonaviciene; Wolfgang Linz; Ursula Schindler; Hartmut Rütten; Kerstin Amann
Journal:  Kidney Blood Press Res       Date:  2007-06-15       Impact factor: 2.687

2.  The measurement of total "sodium space" and total body sodium in normal individuals and in patients with cardiac edema.

Authors:  G F WARNER; E L DOBSON; C E RODGERS; M E JOHNSTON; N PACE
Journal:  Circulation       Date:  1952-06       Impact factor: 29.690

3.  Effect of nesiritide in patients with acute decompensated heart failure.

Authors:  C M O'Connor; R C Starling; A F Hernandez; P W Armstrong; K Dickstein; V Hasselblad; G M Heizer; M Komajda; B M Massie; J J V McMurray; M S Nieminen; C J Reist; J L Rouleau; K Swedberg; K F Adams; S D Anker; D Atar; A Battler; R Botero; N R Bohidar; J Butler; N Clausell; R Corbalán; M R Costanzo; U Dahlstrom; L I Deckelbaum; R Diaz; M E Dunlap; J A Ezekowitz; D Feldman; G M Felker; G C Fonarow; D Gennevois; S S Gottlieb; J A Hill; J E Hollander; J G Howlett; M P Hudson; R D Kociol; H Krum; A Laucevicius; W C Levy; G F Méndez; M Metra; S Mittal; B-H Oh; N L Pereira; P Ponikowski; W H W Tang; W H Wilson; S Tanomsup; J R Teerlink; F Triposkiadis; R W Troughton; A A Voors; D J Whellan; F Zannad; R M Califf
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

4.  Influence of angiotensin on the early progression of heart failure.

Authors:  T E Lohmeier; H L Mizelle; G A Reinhart; J P Montani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-01       Impact factor: 3.619

5.  Interactions between intrarenal epinephrine receptors and the renal baroreceptor in the control of PRA in conscious dogs.

Authors:  E R Farhi; J R Cant; A C Barger
Journal:  Circ Res       Date:  1982-04       Impact factor: 17.367

6.  Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes.

Authors:  Mihai Gheorghiade; Stephen J Greene; Gerasimos Filippatos; Erland Erdmann; Roberto Ferrari; Phillip D Levy; Aldo Maggioni; Christina Nowack; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2012-06-19       Impact factor: 15.534

7.  The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.

Authors:  Simon Thackray; Joanne Easthaugh; Nick Freemantle; John G F Cleland
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

8.  Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure.

Authors:  Maria Patarroyo; Edgard Wehbe; Mazen Hanna; David O Taylor; Randall C Starling; Sevag Demirjian; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2012-10-10       Impact factor: 24.094

Review 9.  Pathogenesis of pulmonary edema: learning from high-altitude pulmonary edema.

Authors:  Claudio Sartori; Yves Allemann; Urs Scherrer
Journal:  Respir Physiol Neurobiol       Date:  2007-04-25       Impact factor: 1.931

10.  Atrial natriuretic peptide increases human capillary filtration and venous distensibility.

Authors:  S Ando; T Imaizumi; S Harada; Y Hirooka; A Takeshita
Journal:  J Hypertens       Date:  1992-05       Impact factor: 4.844

View more
  16 in total

1.  Fluid Management in Patients with Chronic Heart Failure.

Authors:  Pierpaolo Pellicori; Kuldeep Kaur; Andrew L Clark
Journal:  Card Fail Rev       Date:  2015-10

2.  Pulmonary Oedema-Therapeutic Targets.

Authors:  Ovidiu Chioncel; Sean P Collins; Andrew P Ambrosy; Mihai Gheorghiade; Gerasimos Filippatos
Journal:  Card Fail Rev       Date:  2015-04

Review 3.  Changes in renal function in congestive heart failure.

Authors:  Guido Boerrigter; Berthold Hocher; Harald Lapp
Journal:  Curr Heart Fail Rep       Date:  2013-12

4.  Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).

Authors:  Marat Fudim; Kishan S Parikh; Allison Dunning; Adam D DeVore; Robert J Mentz; Phillip J Schulte; Paul W Armstrong; Justin A Ezekowitz; W H Wilson Tang; John J V McMurray; Adriaan A Voors; Mark H Drazner; Christopher M O'Connor; Adrian F Hernandez; Chetan B Patel
Journal:  Am J Cardiol       Date:  2018-08-03       Impact factor: 2.778

5.  Effect of β2-adrenergic receptor stimulation on lung fluid in stable heart failure patients.

Authors:  Bryan J Taylor; Eric M Snyder; Maile L Richert; Courtney M Wheatley; Steven C Chase; Lyle J Olson; Bruce D Johnson
Journal:  J Heart Lung Transplant       Date:  2016-10-02       Impact factor: 10.247

6.  Noise exposure and its relationship with postinfarction cardiac remodeling: implications for NLRP3 inflammasome activation.

Authors:  Yanzhao Wei; Wei Li; Shuang Yang; Peng Zhong; Yingying Bi; Yanhong Tang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

7.  Relation of Intravascular Volume Profiles to Heart Failure Progression and Clinical Outcomes.

Authors:  Kevin L Kelly; Robert J Wentz; Bruce D Johnson; Wayne L Miller
Journal:  Am J Cardiol       Date:  2021-06-29       Impact factor: 3.133

8.  Notchless is required for axial skeleton formation in mice.

Authors:  Sarah Beck-Cormier; Marie Escande; Céline Souilhol; Sandrine Vandormael-Pournin; Sophie Sourice; Paul Pilet; Charles Babinet; Michel Cohen-Tannoudji
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

9.  Translational Medicine in Pulmonary-Renal Crosstalk: Therapeutic Targeting of p-Cresyl Sulfate Triggered Nonspecific ROS and Chemoattractants in Dyspneic Patients with Uremic Lung Injury.

Authors:  Jia-Feng Chang; Shih-Shin Liang; Pounraj Thanasekaran; Hsueh-Wei Chang; Li-Li Wen; Chung-Hua Chen; Jian-Chiun Liou; Jih-Chen Yeh; Shih-Hao Liu; Huei-Min Dai; Wei-Ning Lin
Journal:  J Clin Med       Date:  2018-09-09       Impact factor: 4.241

10.  Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey.

Authors:  Ahmad Shoaib; M Farag; J Nolan; A Rigby; A Patwala; M Rashid; C S Kwok; R Perveen; A L Clark; M Komajda; J G F Cleland
Journal:  Clin Res Cardiol       Date:  2018-10-25       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.